Navigation Links
Drug can quickly mobilize an army of cells to repair injury

let the appropriate cells find their way through the circulation to the site of injury or low oxygen," he says. "That way you enhance a normal repair mechanism instead of using the brute force of injecting a mixture of many cell types from bone marrow into the affected area."

The research group has also shown that after treating human subjects with AMD3100 or G-CSF, angiogenic cells can be collected from the blood by a technique that separates them and concentrates them. They found that the cells maintain their function after freezing and so can be stored for future use.

"It's possible that if a patient was scheduled to have a procedure that would damage blood vessels, such as angioplasty, physicians could collect angiogenic cells before the procedure and use them during the patient's recovery," Link says.

Angiogenic cells may also help improve blood flow in peripheral vascular disease, a problem often encountered in diabetic patients, who can suffer from poor circulation in their limbs that causes pain or sores and may lead to amputation.

The potential of the two drugs for treating such conditions was addressed in another study by the research group, also published in a recent issue of Blood, which tested the effect of both AMD3100 and G-CSF in mice after blood flow to a leg had been impaired. Both drugs induced new blood vessels to grow in the affected legs of the mice, and combining the drugs had the greatest benefit.

"We are now working to set up a clinical trial to test G-CSF in patients with peripheral vascular disease," Link says. "We chose G-CSF in this case because it's not essential that the treatment act quickly - the condition has been present for months before the patients are treated - and the drug already has FDA approval for medical use. We want to find out if this treatment will lead to long-lasting improvement in blood flow, heal ulcers, relieve pain and prevent amputations."


'"/>

Source:Washington University School of Medicine


Page: 1 2

Related biology news :

1. To translate touch, the brain can quickly rearrange its sense of the body
2. Gene patterns in white blood cells quickly diagnose disease
3. Animals can change genes quickly to keep up with viral ingenuity
4. New MRI technique quickly builds 3-D images of knees
5. Mussels evolve quickly to defend against invasive crabs
6. Biodegradable napkin -- featuring sensitive nanofibers -- may quickly detect biohazards
7. A new portable biosensor detects traces of contaminants in food more quickly and cheaply
8. Asexual worm quickly adapts to soil contamination
9. Resistant HIV quickly hides in infants cells
10. Arctic ice retreating more quickly than computer models project
11. Particle size matters to bacteria ability to immobilize heavy metals
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Drug can quickly mobilize army cells repair injury

(Date:3/31/2015)... March 31, 2015  Elephant Talk Communications Corp. (NYSE ... provider of Software Defined Network Architecture (ET Software DNA® ... revenue of approximately $20.4 million for the year ended ... million for the year ended December 31, 2013. ... Company had completed its multi-year transition away from its ...
(Date:3/30/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ... Gesture Recognition Market in Automotive Sector 2014-2018" report ... Global Gesture Recognition market in Automotive Sector to grow ... Gesture recognition is the ability of a ... an individual. Gesture recognition technology can be 2D-based or ...
(Date:3/24/2015)... and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) has announced ... 2015-2019" report to their offering. The ... at a CAGR of 23.5 percent over the period ... and the growth prospects of the Global Iris Recognition ... size, the report considers the revenue generated from sales ...
Breaking Biology News(10 mins):Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
... by Scripps Research Professor Benjamin Cravatt, Ph.D., is ... The Journal of Biological Chemistry. , The new ... suggested-for the biosynthesis of neurotransmitter lipids, N-acyl ethanolamines ... The high activity of the enzyme a/b hydrolase4 ...
... bacteria, viruses and other dangerous substances in hospitals, airplanes ... easy as wiping a napkin or paper towel across ... "It's very inexpensive, it wouldn't require that someone be ... activated for whatever you want to find," said Margaret ...
... specifically targets mutant enzymes or "oncoproteins" that have run ... as these drugs are, cancer cells with their backs ... A major goal of cancer research is to frustrate ... issue of Cancer Cell, investigators at the Salk Institute ...
Cached Biology News:Study shows enzyme builds neurotransmitters via newly discovered pathway 2Biodegradable napkin -- featuring sensitive nanofibers -- may quickly detect biohazards 2Distinguishing friend from foe in the battle against cancer 2Distinguishing friend from foe in the battle against cancer 3
(Date:4/1/2015)... 01, 2015 Proove Biosciences , ... , presented two scientific posters at the Annual Clinical ... The four-day event was hosted at the Salt Palace ... to educating genetic and genomic professionals on breakthrough advances ... Insomnia: Study on the Role of DAT1 in Risk ...
(Date:4/1/2015)... , Mar. 30, 2015 Research and Markets ... addition of the "Forensic Technologies and Services ... their offering. This report analyzes the ... US$ Million by the following Segments: Forensic Databases, ... and Others. Annual estimates and forecasts ...
(Date:4/1/2015)... YORK CITY and LONDON , ... market research reports and solutions, MarketResearch.com is pleased to highlight ... be a year of market growth and opportunity for the ... cell company or cord blood bank, competing in the stem ... conditions, predict industry trends, and act on market changes before ...
(Date:3/31/2015)... 2015 CytoSorbents Corporation (NASDAQ CM: CTSO), ... to treat critically-ill and cardiac surgery patients in ... reports financial results for the fiscal year ending ... product revenues were a record $3.1M, an increase ... revenues of $0.8M Highlights for the Year Ending ...
Breaking Biology Technology:Proove Biosciences Presents Research Studies at Annual Clinical Genetics Meeting 2015 2Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 2Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 3Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 4Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 5Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 6Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 7MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 2MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 3MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 4CytoSorbents Reports Record 2014 Revenue 2CytoSorbents Reports Record 2014 Revenue 3CytoSorbents Reports Record 2014 Revenue 4CytoSorbents Reports Record 2014 Revenue 5CytoSorbents Reports Record 2014 Revenue 6CytoSorbents Reports Record 2014 Revenue 7CytoSorbents Reports Record 2014 Revenue 8CytoSorbents Reports Record 2014 Revenue 9CytoSorbents Reports Record 2014 Revenue 10CytoSorbents Reports Record 2014 Revenue 11
... Pharmaceuticals, Inc.,a privately held biopharmaceutical company developing anti-inflammatory,drugs, ... varespladib (A-002) at,the American Heart Association (AHA) Annual ... Phase II trials in varespladib for the,treatment of ... and its,collaborators released new data from the Phase ...
... November 11 , - Revenues Expected to be ... The Binding Site Limited ("The Binding Site" or the ... update for the year ended 30th September 2008. The ... Revenues are expected to be GBP38.9 million, representing ...
... Cardium Therapeutics,(Amex: CXM ) today reported financial results and ... revised business strategies,for its three operating units: (1) InnerCool Therapies, ... (Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO ), ... InnerCool ...
Cached Biology Technology:Anthera's Varespladib Demonstrates Significant Anti-Inflammatory Effect and LDL Reduction in Patients With Coronary Heart Disease 2The Binding Site Announces Trading Update for Year Ended September 30th 2008 2The Binding Site Announces Trading Update for Year Ended September 30th 2008 3Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 2Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 3Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 4Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 5Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 6Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 7Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 8Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 9Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 10Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 11
LTBP-2 (7B10)...
... polyclonal to Kv4.2 Immunogen Synthetic ... to amino acids 23-43 of Rat Kv4.2. ... Rat.Expected to cross-react with Human (100% identity ... Rabbit (100% identity with immunogen) and Ferret ...
Mouse Anti-Gemin2...
RayBio Human Angiogenesis Antibody Array 2.1 (8 array membranes) with Accessory, detects 23 angiogenic factors (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
Biology Products: